American Shared Hospital Services (AMS)

NYSEAMERICAN: AMS · USD

$1.32

+0.05 (+3.9%)· Recorded snapshot

Market cap	8.8M
Revenue (ttm)	30.4M
Net income (ttm)	-1.8M
EPS (ttm)	-$0.26
Shares out	6.7M
Volume	11,076
Beta	0.29

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 30.4M
Net income (ttm): -1.8M
EPS (ttm): -$0.26
Market cap: 8.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-12.1

P25 n/aP50 n/aP75 n/a

ROIC-5.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AMS indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000744825
Company name	American Shared Hospital Services
Country	United States
Country code	US
CUSIP number	029595105
Earnings date	2026-11-12
Earnings time	bmo
Employees	84
Employees change	2
Employees growth	2.44%
Enterprise value	$22.8M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1980
Industry	Medical Care Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	US0295951059
Last 10-K release date	2026-03-31
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$8.8M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$1.32
Price currency	USD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	AMS
U.S. state	California
Website	https://www.ashs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	19.71x
Average P/E ratio (5Y)	21.96x
Earnings yield	-20.07%
EV/EBITDA	7.17x
EV/FCF	6.35x
EV/Sales	0.74x
FCF / EV yield	15.74%
FCF yield	41.86%
Forward EV/Sales	1.31x
Forward P/S	0.49x
Industry forward P/E	14.81x
Industry P/E	18.21x
P/(FCF - SBC) ratio	2.7x
P/(OCF - SBC) ratio	1.71x
P/B ratio	0.36x
P/FCF ratio	2.39x
P/OCF ratio	1.58x
P/S ratio	0.28x
Price / tangible book value	0.39x
Price/EBITDA ratio	2.69x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-7.44%
EBITDA margin	10.3%
FCF margin	11.62%
Gross margin	34.83%
Operating margin	-7.44%
Pretax margin	-10.58%
Profit margin	-5.83%
Profit per employee	$-21,119
Revenue per employee	$362,060
ROA	-2.44%
ROA (5Y)	2.13%
ROCE	-7.53%
ROE	-12.06%
ROE (5Y)	1.22%
ROIC	-5.47%
ROIC (5Y)	3.03%
SBC / revenue	1.33%
Tax / revenue	0.26%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth (QoQ)	3.32%
FCF growth 3Y	-13.72%
FCF growth 5Y	-10.88%
Gross profit growth	-20.97%
Gross profit growth (Q)	-11.29%
Gross profit growth 3Y	-8.03%
Gross profit growth 5Y	-1.02%
Net income growth years	0
OCF growth	86.03%
OCF growth (QoQ)	4.05%
OCF growth 10Y	-4.04%
OCF growth 3Y	-13.8%
OCF growth 5Y	-4.48%
Revenue growth	3.97%
Revenue growth (Q)	19.22%
Revenue growth (QoQ)	19%
Revenue growth 10Y	6.12%
Revenue growth 3Y	14.32%
Revenue growth 5Y	10.91%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.8M
Depreciation and amortization	$5.4M
EBIT	$-2.3M
EBITDA	$3.1M
EPS	$-0.26
FCF per share	$0.53
Financing cash flow	$-8.1M
Free cash flow	$3.5M
Free cash flow minus SBC	$3.1M
Gross profit	$10.6M
Income taxes	$78,000
Investing cash flow	$-1.8M
Net borrowing	$-8M
Net cash flow	$-4.6M
Net income	$-1.8M
Operating cash flow minus SBC	$4.9M
Operating income	$-2.3M
Revenue	$30.4M
Stock-based compensation	$404,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.71
Book value per share	$3.49
Debt / EBITDA	5.46
Debt / equity	0.8
Debt / FCF	5.81
Goodwill	$1.3M
Interest coverage	-1.72
Long-term assets	$35.1M
Long-term liabilities	$4.3M
Net cash (debt)	$-14M
Net cash / market cap	-165.91%
Net debt / EBITDA	4.47
Net debt / equity	0.54
Net debt / FCF	3.96
Piotroski F-Score	3
Property, plant and equipment	$33.5M
Shareholders' equity	$25.8M
Tangible book value	$21.8M
Tangible book value per share	$3.29
Total assets	$52.5M
Total cash	$6.5M
Total debt	$20.5M
Total liabilities	$26.7M
WACC	5.3%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.52
Current assets	$17.4M
Current liabilities	$22.4M
Current ratio	0.77
Net working capital	$4.8M
Quick ratio	0.73
Working capital	$-5.1M
Working capital turnover	-41.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.2%
Dividend growth (3Y)	5.35%
Dividend growth (5Y)	9.63%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.05
Shareholder yield	-2.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-54.48%
10Y return CAGR	-7.57%
10Y total return	-54.48%
150-day SMA	$1.46
15Y price change	-50%
15Y return CAGR	-4.52%
15Y total return	-50%
1D price change	3.94%
1M price change	-7.04%
1M total return	-7.04%
1W price change	5.6%
1W total return	5.6%
1Y price change	-40%
1Y return CAGR	-40.02%
1Y total return	-40%
20-day SMA	$1.30
200-day SMA	$1.62
20Y price change	-79.57%
20Y return CAGR	-7.53%
20Y total return	-79.09%
3M price change	-14.29%
3M total return	-14.29%
3Y price change	-43.83%
3Y return CAGR	-17.49%
3Y total return	-43.83%
50-day SMA	$1.40
50-day SMA vs 200-day SMA	50under200
52-week high	$2.39
52-week high date	2026-02-12
52-week low	$1.21
52-week low date	2026-10-16
5Y price change	-53.52%
5Y return CAGR	-14.21%
5Y total return	-53.52%
All-time high	$12.13
All-time high date	1988-06-29
All-time low	$0.19
All-time low date	1994-09-07
Average true range (ATR)	$0.05
Average volume	9.7K
Beta (1Y)	0.88
Beta (2Y)	0.3
Beta (5Y)	0.29
Change from 52-week high	-44.77%
Change from 52-week low	9.09%
Change from all-time high	-89.11%
Change from all-time low	604%
Change from open	0%
Day's gap	3.94%
Dollar volume	$14,620
High price	$1.32
Low price	$1.32
Monthly RSI	26.98
Open price	$1.32
Previous close	$1.27
Price vs 150-day SMA	-9.53%
Price vs 20-day SMA	1.38%
Price vs 200-day SMA	-18.62%
Price vs 50-day SMA	-5.38%
Relative volume	1.15
RSI	49.05
Sharpe ratio	-0.63
Sharpe ratio (3Y)	-0.25
Sharpe ratio (5Y)	-0.19
Sortino ratio	-0.84
Sortino ratio (3Y)	-0.25
Sortino ratio (5Y)	-0.15
Volume	11.1K
Weekly RSI	40.16
YTD price change	-37.44%
YTD total return	-37.44%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4.4M
Float percentage	66.34%
Shares change (QoQ)	2.19%
Shares change (YoY)	2.2%
Shares held by insiders	33.66%
Shares held by institutions	7.6%
Shares outstanding	6.7M
Short % of float	0.19%
Short % of shares	0.12%
Short ratio	0.9 days

Deeper analysis on AMS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AMS report

Is a complete AMS research report available?

No complete published report is available for American Shared Hospital Services (AMS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

American Shared Hospital Services (AMS)

Price

Financial snapshot

Fair-value bridge

Latest news · AMS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AMS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AMS

Frequently asked questions